Sapreme Technologies
About:
Sapreme Technologies is a biotechnology company focused on improving the delivery and efficacy of macromolecule therapeutic.
Website: https://sapreme-technologies.com/
Top Investors: Aglaia BioMedical Ventures
Description:
Sapreme Technologies is a biotechnology company focused on improving the delivery and efficacy of macromolecule therapeutic.
Total Funding Amount:
15M EUR
Estimated Revenue Range:
$1M to $10M
Headquarters Location:
Bilthoven, Utrecht, The Netherlands
Founded Date:
2016-01-01
Founders:
Ruben Postel
Number of Employees:
11-50
Last Funding Date:
2021-10-07
IPO Status:
Private
Industries:
© 2025 bioDAO.ai